A Florida lab owner allegedly treated Medicare like a personal ATM—until federal prosecutors moved to take his Rolls-Royce and estate.
What prosecutors say happened in the $52 million Medicare scheme
Federal prosecutors say Sean Alterman owned and operated Live Beyond Medical MGMT, LLC and Dynix Diagnostics LLC, and used them to bill Medicare for genetic tests that were not medically necessary. Authorities say the labs submitted about $52 million in claims and Medicare paid about $36 million. Alterman pleaded guilty on January 15, 2026, to conspiracy to commit health care fraud and conspiracy to offer and pay kickbacks.
Florida Man Forfeits Rolls-Royce, Estate After Guilty Plea in $52M Medicare Scam
https://t.co/Gz2fVY7h1H— Townhall Updates (@TownhallUpdates) January 30, 2026
Investigators say the operation relied on telemarketing aimed at Medicare beneficiaries, including seniors, to generate test requests. Prosecutors describe “doctor chasing” as a key component—obtaining orders without legitimate patient examinations—along with kickbacks that helped keep the pipeline of orders moving. The government’s public statements frame the alleged conduct as theft from taxpayers and patients, not a paperwork error, and emphasize that enforcement will pursue forfeiture and prison time.
“Doctor chasing,” shell companies, and the money trail
According to federal case announcements, Alterman personally profited about $5.5 million through shell companies identified as Shivv LLC and Shank LLC. That detail matters because it illustrates how fraud proceeds can be separated from the billing entity and routed into side businesses, complicating detection and recovery. Prosecutors say the funds were used to buy luxury assets, including a 2022 Rolls-Royce Ghost, reinforcing their argument that the scheme was driven by personal enrichment.
Alterman agreed to forfeit both the Rolls-Royce and a Lake Worth estate that authorities say were purchased with proceeds tied to the fraud. Asset forfeiture is one of the few tools that can directly claw back money after improper Medicare payments go out the door. While the final restitution picture is not yet clear from public reporting, the forfeiture agreement signals the government is pursuing more than a conviction—it is also seeking to unwind benefits gained from the alleged misconduct.
Why Florida remains a hot spot for Medicare telemarketing fraud
The case landed in the Southern District of Florida, a region that has repeatedly been targeted for Medicare fraud enforcement because of its high concentration of beneficiaries and healthcare businesses. Federal authorities have warned for years that telemarketing-based schemes can exploit seniors and drain program funds through unnecessary services. This case also fits a broader national pattern of genetic-testing fraud, where high reimbursements and aggressive marketing can create incentives for questionable ordering practices.
Enforcement pressure grows as Washington focuses on waste and accountability
Federal officials tied the prosecution to the Justice Department’s Health Care Fraud Strike Force, created in 2007, which has charged thousands of defendants and alleges tens of billions of dollars in fraudulent billing across multiple districts. That broader enforcement context matters to taxpayers who are fed up with waste and overspending, because Medicare losses ultimately feed higher costs and heavier pressure for more government spending. Even when fraud is prosecuted, the money is not automatically recovered.
Sentencing is set for April 16, 2026, and federal announcements state Alterman could face up to 15 years in prison. Public summaries do not provide a full list of additional defendants in this matter, even though recruiters and other actors are referenced in descriptions of how the alleged scheme operated. For readers watching government accountability closely, the key takeaway is that aggressive enforcement can deter copycats—but prevention and faster payment controls remain critical when billions flow through federal health programs.
Sources:
Florida lab owner pleads guilty in $52M Medicare genetic test fraud scheme